Status:
RECRUITING
Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix
Lead Sponsor:
M.D. Anderson Cancer Center
Conditions:
Cervical Large Cell Neuroendocrine Carcinoma
Cervical Neuroendocrine Carcinoma
Eligibility:
All Genders
Brief Summary
This study collects information and data on patients with neuroendocrine cervical cancer. Information from this study may be used to better understand the correlation between clinical data, such as pa...
Detailed Description
PRIMARY OBJECTIVES: I. To collect, both prospectively and retrospectively, data on disease characterization, treatment, and outcomes for patients with neuroendocrine carcinoma of the uterine cervix. ...
Eligibility Criteria
Inclusion
- Patients with a personal history of cervical cancer with any portion of neuroendocrine component (including mixed tumors) of the following histologic subtypes:
- Small cell neuroendocrine carcinoma
- Large cell neuroendocrine carcinoma
- Undifferentiated high-grade neuroendocrine carcinoma
- Patients may be in any stage of treatment, surveillance or recurrence at the time of initial participation in the study
- Patients with all stages of disease are considered eligible
- Patients who do not speak English can be eligible if accompanied by an institutional interpreter
- Patients who are receiving or have received treatment at any facility, including but not limited to M. D. Anderson Cancer Center are eligible
- Patient may be residents of any country and be of any ethnic background
- Patients who request to participate in the study, regardless of the method by which they learned of it, are eligible to participate, including, but not limited to patients who seek participation via the website
- Next of kin or legal authorized representatives of patients who are deceased but had a history of neuroendocrine carcinoma (NEC) of the cervix are eligible to participate
- Next of kin or legal authorized representatives of patients must read and speak English
Exclusion
- Patients with other histologic subtypes of NEC of the cervix including typical and atypical carcinoid tumors
Key Trial Info
Start Date :
May 16 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2044
Estimated Enrollment :
750 Patients enrolled
Trial Details
Trial ID
NCT04723095
Start Date
May 16 2013
End Date
January 1 2044
Last Update
September 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
M D Anderson Cancer Center
Houston, Texas, United States, 77030